3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
11
Squamous Cell Carcinoma of Head and Neck
8
Oropharyngeal Neoplasms
7
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Lung Neoplasms
6
Urinary Bladder Neoplasms
5
Ovarian Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma
4
Sarcoma
3
Hypopharyngeal Neoplasms
3
Fallopian Tube Neoplasms
3
Urethral Neoplasms
2
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Paranasal Sinus Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mesothelioma, Malignant
2
Klatskin Tumor
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Testicular Neoplasms
1
Stomatitis
1
Interventions
Radiotherapy
9
Doxorubicin
7
pazopanib
5
palbociclib
4
Trabectedin
4
Gemcitabine
4
ribociclib
3
pembrolizumab
3
eribulin
3
Magnetic Resonance Spectroscopy
3
selinexor
2
liposomal doxorubicin
2
avelumab
2
abemaciclib
2
Sunitinib
2
Radiation Dose Hypofractionation
2
Radiation
2
Immunoglobulin G
2
Ifosfamide
2
Docetaxel
2
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
2
zimberelimab
1
temsirolimus
1
sotigalimab
1
sodium thiosulfate
1
sitravatinib
1
silmitasertib
1
sargramostim
1
romidepsin
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liposarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled